Letko, Brosseau & Associates Inc Kodiak Sciences Inc. Transaction History

Letko, Brosseau & Associates Inc

  • $5.37 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$110.45 - $164.47 $908,451 - $1.35 Million
-8,225 Closed
0 $0
Q4 2020

Feb 05, 2021
SELL
$60.78 - $154.03 $395,070 - $1 Million
-6,500 Reduced 44.14%
8,225 $1.21 Million
Q3 2020

Nov 09, 2020
SELL
$45.05 - $59.27 $24,777 - $32,598
-550 Reduced 3.6%
14,725 $872,000
Q2 2020

Aug 07, 2020
BUY
$42.74 - $66.25 $652,853 - $1.01 Million
15,275 New
15,275 $827,000

Others Institutions Holding KOD

# of Institutions
98
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $450M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email